SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-075691
Filing Date
2014-12-23
Accepted
2014-12-23 16:23:21
Documents
8
Period of Report
2014-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v397193_8k.htm 8-K 29539
2 EXHIBIT 4.1 v397193_ex4-1.htm EX-4.1 71674
3 EXHIBIT 4.2 v397193_ex4-2.htm EX-4.2 79674
4 EXHIBIT 10.1 v397193_ex10-1.htm EX-10.1 209002
5 EXHIBIT 10.2 v397193_ex10-2.htm EX-10.2 150598
6 EXHIBIT 10.3 v397193_ex10-3.htm EX-10.3 263335
7 EXHIBIT 99.1 v397193_ex99-1.htm EX-99.1 13814
8 GRAPHIC image_001.jpg GRAPHIC 2121
  Complete submission text file 0001144204-14-075691.txt   822113
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32715 | Film No.: 141307187
SIC: 2835 In Vitro & In Vivo Diagnostic Substances